Key facts
- This page summarizes Geraint Phillips's Form 4 filing for BIOLIFE SOLUTIONS INC (BLFS).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 12 Mar 2024, 21:44.
Geraint Phillips - 08 Mar 2024 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)
- Reporting relationship
- SVP, Global Operations
- Issuer ticker
- BLFS
- Reported as of
- 08 Mar 2024
- Net transaction value
- -$63,315
- SEC form
- 4
- Accepted by SEC
- 12 Mar 2024, 21:44:08 UTC
- Prior SEC filing
- 23 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Geraint Phillips
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Geraint Phillips filed Form 4 for BIOLIFE SOLUTIONS INC (BLFS) on 12 Mar 2024.
Change
- Previous filing in this sequence was filed on 23 Feb 2024.
- Current net transaction value: -$63,315.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BLFS
transaction
Common Stock
Award
- Transaction value
- Shares
- +11,682
- Change %
- +20%
- Price
- Shares after
- 69,802
- Date
- 08 Mar 2024
- Ownership
- Direct
- Footnotes
- F1
BLFS
transaction
Common Stock
Sale
- Transaction value
- $3,589
- Shares
- -206
- Change %
- -0.3%
- Price
- $17.42
- Shares after
- 69,596
- Date
- 11 Mar 2024
- Ownership
- Direct
- Footnotes
- F2
BLFS
transaction
Common Stock
Sale
- Transaction value
- $59,727
- Shares
- -3,598
- Change %
- -5.2%
- Price
- $16.60
- Shares after
- 65,998
- Date
- 12 Mar 2024
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 2 footnotes
Footnote F1
The restricted stock was granted pursuant to the 2013 Performance Incentive Plan. In accordance with the terms of the grant, the restricted stock vested as to 125% of the reported number of shares reported in the reporting person's Form 4 reporting the grant based on the registrant's total shareholder return during the period beginning on January 1, 2022 through December 31, 2023 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date).
Footnote F2
The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.